Trial Profile
A single-dose, randomized, open-label, parallel-group study to evaluate the ethnic/racial difference in pharmacokinetics of cariprazine between Japanese, Korean, Taiwanese, and Caucasian healthy adult male volunteers
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Oct 2016
Price :
$35
*
At a glance
- Drugs Cariprazine (Primary)
- Indications Schizophrenia
- Focus Pharmacokinetics
- Sponsors Mitsubishi Tanabe Pharma Corporation
- 08 Oct 2016 New trial record